zoledronic acid has been researched along with Mastocytosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adami, S; Bonadonna, P; Gatti, D; Idolazzi, L; Kunnathully, V; Orsolini, G; Rossini, M; Tripi, G; Viapiana, O; Zamò, A; Zanotti, R | 1 |
1 review(s) available for zoledronic acid and Mastocytosis
Article | Year |
---|---|
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.
Topics: Bone Density; Bone Density Conservation Agents; Cytokines; Diphosphonates; Histamine; Humans; Imidazoles; Mastocytosis; Osteoclasts; Osteoporosis; Prevalence; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction; Zoledronic Acid | 2016 |